Zydus Cadila today announced that it has received permission to start the phase III clinical trials in the COVID-19 patients with its biological therapy, Pegylated Interferon alpha-2b, ‘PegiHep^TM’ from Drugs Controller General of India (DCGI).  The trials will be conducted on 250 patients across 20-25 centres in India, starting in December.

The company has made an investment of Rs 5,477 crore for the expansion. Upon completion, the company’s capacity will increase to 136.25 MTPA, making it the third-largest company in the world, outside China.

The market opened in green on December 04, 2020.

On Friday, the stock Indian Railway Catering & Tourism Corporation Limited has surged over 12 per cent and marked an intraday high of Rs 1,597. Technically, the stock has given a downward sloping trendline breakout on the daily timeframe formed by connecting swing highs since June 2020.

The stock of Poly Medicure Limited was picked by our Bollinger Band squeeze scanner, which suggests that the stock is near a consolidation breakout.

The market opened in green on December 04, 2020, overall volumes in futures & options currently stand at 6,05,62,862 contracts with a turnover of Rs. 49,24,536.60 crore.

The market opened in green on December 04, 2020, overall volumes in futures & options currently stand at 6,05,62,862 contracts with a turnover of Rs. 49,24,536.60 crore.

Vakrangee Ltd announced on Thursday after the market hours that it has entered into a partnership with SBM Bank India to provide banking business correspondent (BC) services for pan India at Nextgen Vakrangee Kendra franchisees.

MHRIL: The company has subscribed to 6.67 per cent of the equity share capital of Rocksport for a cash consideration of Rs 3.05 crore.

Going into the final trading session of the week, the advantage is again with the bulls despite the lackluster cues from the global peers. SGX Nifty is trading higher by 38 points and at 13,241 levels. The early advantage to the bulls is due to the statement made by the Finance Ministry.